Table 2.

Proportions of different drug classes/drugs among individuals with major NCD and reference individuals

	Major NCD	Reference group	p-Valuea
Number of individuals	10,540	12,287	NA
RAS inhibitors	5941 (56.4)	8532 (69.4)	<0.001
BBs	6842 (64.9)	8879 (72.3)	<0.001
MRAs	1852 (17.6)	3014 (24.5)	<0.001
Loop diuretics	5927 (56.2)	6657 (54.2)	0.002
Digitalis glycosides	1043 (9.9)	1215 (9.9)	0.986
SGLT2 inhibitors	120 (1.1)	195 (1.6)	0.004

Data are expressed as n (%)

BBs β-blockers, MRAs mineralocorticoid receptor antagonists, NCD neurocognitive disorder, RAS renin-angiotensin system, SGLT2 sodium-glucose linked transporter-2, NA not available

^aChi-square tests